-+ 0.00%
-+ 0.00%
-+ 0.00%

Keybanc Maintains Overweight on Rapid Micro Biosystems, Lowers Price Target to $5

Benzinga·05/29/2026 15:49:58
Listen to the news
Keybanc analyst Paul Knight maintains Rapid Micro Biosystems (NASDAQ:RPID) with a Overweight and lowers the price target from $8 to $5.